Efficacy and safety of sorafenib combined with TACE in the treatment of advanced hepatocellular carcinoma: A meta-analysis.

Li, Dailong; Pang, Yaqi; Xu, Lu; Xu, Xinhua

Li, Dailong; Pang, Yaqi; Xu, Lu; Xu, Xinhua.

Affiliation

Li D; Department of Oncology, the First Clinical Medical College of Three Gorges University, Yichang Central People's Hospital, Yichang 443003, People's Republic of China.

J BUON ; 26(4): 1355-1364, 2021.

Article in En | MEDLINE | ID: mdl-34564992

Subject(s)

Antineoplastic Agents/therapeutic use; Carcinoma, Hepatocellular/therapy; Chemoembolization, Therapeutic; Liver Neoplasms/therapy; Sorafenib/therapeutic use; Antineoplastic Agents/adverse effects; Carcinoma, Hepatocellular/pathology; Chemoembolization, Therapeutic/methods; Combined Modality Therapy; Hepatic Artery; Humans; Liver Neoplasms/pathology; Sorafenib/adverse effects; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Therapeutic Methods and Therapies TCIM: Terapias_biologicas / Aromoterapia Main subject: Chemoembolization, Therapeutic / Carcinoma, Hepatocellular / Sorafenib / Liver Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Systematic_reviews Language: En Journal: J BUON Year: 2021 Type: Article

Search on Google

Add to My VHL

XML

PubMed Links